FAM3C and alcoholic liver diseases: In particular, diabetes and non-alcoholic liver disease models suggest overexpression of ILEI as potential therapy to overcome glucose intolerance, insulin resistance and liver steatosis linked to reduced ILEI expression in the liver [44, 45].